Observations placeholder
Erbitux
Identifier
018955
Type of Spiritual Experience
Number of hallucinations: 4
Background
A description of the experience
Cetuximab (INN) is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada.
On Dec, 2, 2015: 8,255 people reported to have side effects when taking Erbitux. Among them, 4 people (0.05%) have Hallucination.
Time on Erbitux when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination100.00%0.00%0.00%0.00%0.00%0.00%0.00%
On Nov, 29, 2015: 8,255 people reported to have side effects when taking Erbitux. Among them, 196 people (2.37%) have Death.
Time on Erbitux when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death78.00%22.00%0.00%0.00%0.00%0.00%0.00%